SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

1. PRODUCT AND COMPANY IDENTIFICATION
Product name:Lynestrenol Formulation

Manufacturer or supplier's details
Company: Organon & Co.
Address:

30 Hudson Street, 33nd floor
Jersey City, New Jersey, U.S.A 07302

Telephone:+1-551-430-6000

Emergency telephone number :+1-215-631-6999

E-mail address

EHSSTEWARD@organon.com:

Recommended use of the chemical and restrictions on use
Recommended use: Pharmaceutical
Restrictions on use: Not applicable

2. HAZARDS IDENTIFICATION
Manufacture, Storage and Import of Hazardous Chemicals Rules 1989
Classification
Not classified as hazardous according to criteria laid down in Part I of Schedule-1.
GHS Classification
Germ cell mutagenicity:

Category 1B

Carcinogenicity:

Category 2

Reproductive toxicity:

Category 1ASpecific target organ toxicity repeated exposure:

Category 2 (Blood, Mammary gland, Uterus (including cervix),
Ovary)

GHS label elements
Hazard pictograms:

Signal word:

DangerHazard statements:

H340 May cause genetic defects.
H351 Suspected of causing cancer.
H360Fd May damage fertility. Suspected of damaging the un1 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016born child.
H373 May cause damage to organs (Blood, Mammary gland,
Uterus (including cervix), Ovary) through prolonged or repeatedexposure.
Precautionary statements:

Prevention:
P203 Obtain, read and follow all safety instructions before use.
P260 Do not breathe dust.
P280 Wear protective gloves/ protective clothing/ eye protection/ face protection.
Response:
P318 IF exposed or concerned, get medical advice.
Storage:
P405 Store locked up.
Disposal:
P501 Dispose of contents/ container to an approved waste
disposal plant.

Other hazards which do not result in classification
Dust contact with the eyes can lead to mechanical irritation.
Contact with dust can cause mechanical irritation or drying of the skin.
May form explosive dust-air mixture during processing, handling or other means.
3. COMPOSITION/INFORMATION ON INGREDIENTS
Substance / Mixture:

MixtureComponents
Chemical name

CAS-No.

StarchLynestrenol
Talc
Tocopherol

9005-25-8
52-76-6
14807-96-6
10191-41-0

Concentration (%w/w)>= 20 - < 30>= 5 - < 10>= 1 - < 5>= 0.1 - < 1

4. FIRST AID MEASURES
General advice:

If inhaled:

In case of skin contact:

In case of eye contact:

In the case of accident or if you feel unwell, seek medical advice immediately.
When symptoms persist or in all cases of doubt seek medical
advice.
If inhaled, remove to fresh air.
Get medical attention.
In case of contact, immediately flush skin with soap and plentyof water.
Remove contaminated clothing and shoes.
Get medical attention.
Wash clothing before reuse.
Thoroughly clean shoes before reuse.
If in eyes, rinse well with water.
Get medical attention if irritation develops and persists.
2 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

If swallowed:

Most important symptoms
and effects, both acute anddelayed:Protection of first-aiders:

Notes to physician:

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

If swallowed, DO NOT induce vomiting.
Get medical attention.
Rinse mouth thoroughly with water.
May cause genetic defects.
Suspected of causing cancer.
May damage fertility. Suspected of damaging the unborn
child.
May cause damage to organs through prolonged or repeatedexposure.
Contact with dust can cause mechanical irritation or drying of
the skin.
Dust contact with the eyes can lead to mechanical irritation.
First Aid responders should pay attention to self-protection,and use the recommended personal protective equipment
when the potential for exposure exists (see section 8).
Treat symptomatically and supportively.

5. FIREFIGHTING MEASURES
Suitable extinguishing media:

Water spray
Alcohol-resistant foam
Carbon dioxide (CO2)
Dry chemical
None known.

Unsuitable extinguishingmedia
Specific hazards during firefighting::

Avoid generating dust; fine dust dispersed in air in sufficientconcentrations, and in the presence of an ignition source is apotential dust explosion hazard.
Exposure to combustion products may be a hazard to health.

Hazardous combustion products:

Carbon oxides

Specific extinguishing methods:

Special protective equipment
for firefighters:

Use extinguishing measures that are appropriate to local circumstances and the surrounding environment.
Use water spray to cool unopened containers.
Remove undamaged containers from fire area if it is safe to doso.
Evacuate area.
In the event of fire, wear self-contained breathing apparatus.
Use personal protective equipment.

6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protec- :tive equipment and emergency procedures

Use personal protective equipment.
Follow safe handling advice (see section 7) and personal protective equipment recommendations (see section 8).

Environmental precautions

Avoid release to the environment.
Prevent further leakage or spillage if safe to do so.
Retain and dispose of contaminated wash water.
Local authorities should be advised if significant spillages
cannot be contained.

:

3 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

Methods and materials forcontainment and cleaning up

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016:

Sweep up or vacuum up spillage and collect in suitable container for disposal.
Avoid dispersal of dust in the air (i.e., clearing dust surfaces
with compressed air).
Dust deposits should not be allowed to accumulate on surfaces, as these may form an explosive mixture if they are released into the atmosphere in sufficient concentration.
Local or national regulations may apply to releases and disposal of this material, as well as those materials and items
employed in the cleanup of releases. You will need to determine which regulations are applicable.
Sections 13 and 15 of this SDS provide information regarding
certain local or national requirements.

Technical measures:

Local/Total ventilation:

Advice on safe handling:

Conditions for safe storage:

Materials to avoid:

Static electricity may accumulate and ignite suspended dust
causing an explosion.
Provide adequate precautions, such as electrical grounding
and bonding, or inert atmospheres.
If sufficient ventilation is unavailable, use with local exhaust
ventilation.
Do not get on skin or clothing.
Do not breathe dust.
Do not swallow.
Avoid contact with eyes.
Wash skin thoroughly after handling.
Handle in accordance with good industrial hygiene and safety
practice, based on the results of the workplace exposure assessment
Keep container tightly closed.
Minimize dust generation and accumulation.
Keep container closed when not in use.
Keep away from heat and sources of ignition.
Take precautionary measures against static discharges.
Do not eat, drink or smoke when using this product.
Take care to prevent spills, waste and minimize release to theenvironment.
Keep in properly labelled containers.
Store locked up.
Keep tightly closed.
Store in accordance with the particular national regulations.
Do not store with the following product types:
Strong oxidizing agents

7. HANDLING AND STORAGE

8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Components with workplace control parameters
Components

CAS-No.

Starch

9005-25-8
4 / 16

Value type
(Form ofexposure)
TWA

Control parameters / Permissible
concentration
10 mg/m3

Basis

ACGIH

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Lynestrenol

52-76-6

Talc

14807-96-6

Engineering measures:

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

TWA
Wipe limit
TWA (Total
dust)
TWA (Respirable particulate matter)

1 µg/m3 (OEB 4)
10 µg/100 cm²
10 mg/m3(Silica)
2 mg/m3

Internal
Internal
IN OEL
ACGIH

Containment technologies suitable for controlling compounds
are required to control at source and to prevent migration of
the compound to uncontrolled areas (e.g., vacuum conveying
from a closed system, packout head with inflatable seal fromstationary container, ventilated enclosure, etc.).
All engineering controls should be implemented by facility
design and operated in accordance with GMP principles toprotect products, workers, and the environment.
Essentially no open handling permitted.
Use closed processing systems or containment technologies.

Personal protective equipment
Respiratory protection: If adequate local exhaust ventilation is not available or exposure assessment demonstrates exposures outside the recommended guidelines, use respiratory protection.
Filter type
: Combined particulates and organic vapour type
Hand protection
Material:

Chemical-resistant gloves

Remarks
Eye protection::

Skin and body protection:

Hygiene measures:

Consider double gloving.
Wear safety glasses with side shields or goggles.
If the work environment or activity involves dusty conditions,mists or aerosols, wear the appropriate goggles.
Wear a faceshield or other full face protection if there is apotential for direct contact to the face with dusts, mists, oraerosols.
Work uniform or laboratory coat.
Additional body garments should be used based upon the task
being performed (e.g., sleevelets, apron, gauntlets, disposable
suits) to avoid exposed skin surfaces.
Use appropriate degowning techniques to remove potentiallycontaminated clothing.
If exposure to chemical is likely during typical use, provide eye
flushing systems and safety showers close to the working
place.
When using do not eat, drink or smoke.
Wash contaminated clothing before re-use.
The effective operation of a facility should include review ofengineering controls, proper personal protective equipment,
appropriate degowning and decontamination procedures,industrial hygiene monitoring, medical surveillance and theuse of administrative controls.

9. PHYSICAL AND CHEMICAL PROPERTIES
5 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

Appearance:

powderColour:No data available

Odour

:

No data available

Odour Threshold:

No data available

pH:

No data available

Melting point/freezing point:

No data available

Initial boiling point and boiling
range

:

No data available

Flash point:

Not applicable

Evaporation rate:

Not applicable

Flammability (solid, gas):

May form explosive dust-air mixture during processing, handling or other means.

Flammability (liquids):

No data available

Upper explosion limit / Upper
flammability limit:

No data available

Lower explosion limit / Lower
flammability limit:

No data available

Vapour pressure:

Not applicable

Relative vapour density:

Not applicable

Relative density:

No data available

Density:

No data available

Solubility(ies)
Water solubility:

No data available

Partition coefficient: noctanol/water
Auto-ignition temperature:

Not applicable:

No data available

Decomposition temperature:

No data available

Viscosity
Viscosity, kinematic:

Not applicable

Explosive properties:

Not explosive

Oxidizing properties:

The substance or mixture is not classified as oxidizing.
6 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Particle characteristics
Particle size

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016:

No data available

Reactivity
Chemical stability
Possibility of hazardous reactions:::

Not classified as a reactivity hazard.
Stable under normal conditions.
May form explosive dust-air mixture during processing, handling or other means.
Can react with strong oxidizing agents.

Conditions to avoid:

Incompatible materials
Hazardous decomposition
products::

Heat, flames and sparks.
Avoid dust formation.
Oxidizing agents
No hazardous decomposition products are known.

10. STABILITY AND REACTIVITY

11. TOXICOLOGICAL INFORMATION
Information on likely routes of :exposure

Inhalation
Skin contact
Ingestion
Eye contact

Acute toxicity
Not classified based on available information.
Product:
Acute oral toxicity:

Acute toxicity estimate: > 5,000 mg/kg
Method: Calculation method

Starch:Acute oral toxicity:

LD50 (Rat): > 5,000 mg/kg

Acute dermal toxicity:

LD50 (Rabbit): > 2,000 mg/kg

Lynestrenol:
Acute oral toxicity:

LD50: > 1,000 - 8,000 mg/kg

Components:

Acute toxicity (other routes of :administration)
Talc:
Acute oral toxicity:

LD50 (Mouse): 110 mg/kg
Application Route: Intraperitoneal

LD50 (Rat): > 5,000 mg/kg
Remarks: Based on data from similar materials

Tocopherol:
7 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

Acute oral toxicity:

LD50 (Rat): > 4,000 mg/kg

Acute dermal toxicity:

LD50 (Rat): > 3,000 mg/kg
Assessment: The substance or mixture has no acute dermal
toxicity

Skin corrosion/irritation
Not classified based on available information.
Components:
Talc:
SpeciesResult::RabbitNo skin irritation

Tocopherol:
Species
MethodResult:::RabbitOECD Test Guideline 404
No skin irritation

Serious eye damage/eye irritation
Not classified based on available information.
Components:
Starch:SpeciesResult::RabbitNo eye irritation

Talc:
SpeciesResult::RabbitNo eye irritation

Tocopherol:
Species
MethodResult:::RabbitOECD Test Guideline 405
No eye irritation

Respiratory or skin sensitisation
Skin sensitisation
Not classified based on available information.
Respiratory sensitisation
Not classified based on available information.
Components:
Starch:Test Type
Exposure routes::

Maximisation Test
Skin contact
8 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

SpeciesResult::Guinea pig
negative

Talc:
Exposure routes
SpeciesResult:::Skin contact
Humansnegative

Tocopherol:
Test Type
Exposure routes
Species
MethodResult:::::Local lymph node assay (LLNA)
Skin contact
Mouse
OECD Test Guideline 429
positive

Assessment:

Probability or evidence of low to moderate skin sensitisation
rate in humans

Starch:Genotoxicity in vitro:

Test Type: Bacterial reverse mutation assay (AMES)
Result: negative

Lynestrenol:
Genotoxicity in vitro:

Test Type: Chromosome aberration test in vitro
Result: positive

Germ cell mutagenicity
May cause genetic defects.
Components:

Test Type: sister chromatid exchange assay
Result: positive
Genotoxicity in vivo:

Test Type: Mutagenicity (in vivo mammalian bone-marrowcytogenetic test, chromosomal analysis)
Species: Mouse
Application Route: Intraperitoneal injection
Result: positive
Test Type: sister chromatid exchange assay
Species: Mouse
Application Route: Intraperitoneal injection
Result: positive
Test Type: dominant lethal test
Species: Mouse
Application Route: Intraperitoneal
Result: positive

Germ cell mutagenicity Assessment:

Positive result(s) from in vivo somatic cell mutagenicity tests in
mammals. Evidence that the substance has potential to cause
9 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

mutations to germ cells
Talc:
Genotoxicity in vitro:

Test Type: DNA damage and repair, unscheduled DNA synthesis in mammalian cells (in vitro)
Result: negative

Genotoxicity in vivo:

Test Type: Chromosome aberration test in vitro
Species: Rat
Application Route: Ingestion
Result: negative

Tocopherol:
Genotoxicity in vitro:

Test Type: Chromosome aberration test in vitro
Method: OECD Test Guideline 473
Result: negative
Remarks: Based on data from similar materials

Genotoxicity in vivo:

Test Type: Mammalian erythrocyte micronucleus test (in vivo
cytogenetic assay)
Species: Mouse
Application Route: Ingestion
Result: negative
Remarks: Based on data from similar materials

Lynestrenol:
Species
Application RouteExposure time
ResultTumor Type
Remarks

:
:
:
:
:
:

Mouse
Oral
80 weeks
positive
breast tumors, Liver
Benign and malignant tumor(s)Species
Application RouteExposure time
ResultTumor Type

:
:
:
:
:

Rat
Oral
80 weeks
positive
breast tumors

Carcinogenicity - Assessment:

Limited evidence of carcinogenicity in animal studies

:
:
:
:

Mouse
inhalation (dust/mist/fume)
2 Years
negative

Carcinogenicity
Suspected of causing cancer.
Components:

Talc:
Species
Application RouteExposure time
Result10 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

Tocopherol:
Species
Application RouteExposure time
ResultRemarks

SDS Number:
462438-00017

:
:
:
:
:

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

Rat
Ingestion
104 weeks
negative
Based on data from similar materials

Reproductive toxicity
May damage fertility. Suspected of damaging the unborn child.
Components:
Lynestrenol:
Effects on fertility:

Test Type: Fertility/early embryonic development
Species: Rat, males
Application Route: Oral
Fertility: LOAEL: 20 mg/kg body weight
Remarks: Impaired spermatogenesis
Test Type: Fertility/early embryonic development
Species: Rat, females
Application Route: Oral
Fertility: LOAEL: 375 µg/kg
Result: Maternal toxicity observed., Effects on fertility
Test Type: Fertility/early embryonic development
Species: Rabbit
Application Route: Oral
Fertility: LOAEL: 1,300 µg/kg
Result: Effects on fertility, Postimplantation loss.

Effects on foetal development:

Test Type: Embryo-foetal development
Species: Rat
Application Route: Oral
Developmental Toxicity: LOAEL: 0.1 mg/kg body weight
Result: Effects on foetal development
Test Type: Embryo-foetal development
Species: Rabbit
Application Route: Oral
Developmental Toxicity: LOAEL: 0.1 mg/kg body weight
Result: Effects on foetal development, Postimplantation loss.

Reproductive toxicity - Assessment

Talc:
Effects on foetal develop-:

Some evidence of adverse effects on development, based onanimal experiments., Positive evidence of adverse effects on
sexual function and fertility from human epidemiological studies.

:

Test Type: Embryo-foetal development
11 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

ment

Tocopherol:
Effects on foetal development

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

Species: Rat
Application Route: Ingestion
Result: negative:

Test Type: Embryo-foetal development
Species: Rabbit
Application Route: Ingestion
Result: negative
Remarks: Based on data from similar materials

STOT - single exposure
Not classified based on available information.
STOT - repeated exposure
May cause damage to organs (Blood, Mammary gland, Uterus (including cervix), Ovary) throughprolonged or repeated exposure.
Components:
Lynestrenol:
Target Organs
Assessment::

Blood, Mammary gland, Uterus (including cervix), Ovary
Causes damage to organs through prolonged or repeatedexposure.

Starch:Species
NOAEL
Application RouteExposure time
Method

:
:
:
:
:

Rat
>= 2,000 mg/kg
Skin contact
28 Days
OECD Test Guideline 410

Tocopherol:
Species
NOAEL
Application RouteExposure time
Remarks

:
:
:
:
:

Rat
500 mg/kg
Ingestion
90 DaysBased on data from similar materials

Repeated dose toxicity
Components:

Aspiration toxicity
Not classified based on available information.
Experience with human exposure
Components:
Lynestrenol:
Ingestion:

Target Organs: Uterus (including cervix)
12 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

Target Organs: breasts
Target Organs: ovaries
Target Organs: Blood
Symptoms: Headache, Nausea, Abdominal pain, Rash, Dizziness, Tremors, Sweating, Vomiting, migraine, acne, breast
tenderness, gynecomastia, menstrual irregularities, ovariancysts
Remarks: Used to prevent pregnancy
12. ECOLOGICAL INFORMATION
Ecotoxicity
Components:
Talc:
Toxicity to fish:

LC50 (Brachydanio rerio (zebrafish)): > 100,000 mg/l
Exposure time: 24 h

Tocopherol:
Toxicity to fish:

LC50 (Oncorhynchus mykiss (rainbow trout)): > 100 mg/l
Exposure time: 96 h
Method: OECD Test Guideline 203
Remarks: Based on data from similar materials

Toxicity to daphnia and otheraquatic invertebrates:

EC50 (Daphnia magna (Water flea)): > 23.53 mg/l
Exposure time: 48 h
Method: OECD Test Guideline 202
Remarks: No toxicity at the limit of solubility

Toxicity to algae/aquaticplants:NOEC ( Pseudokirchneriella subcapitata (green algae)): 25.8
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201
Remarks: No toxicity at the limit of solubility
EC50 ( Pseudokirchneriella subcapitata (green algae)): > 25.8
mg/l
Exposure time: 72 h
Method: OECD Test Guideline 201
Remarks: No toxicity at the limit of solubility

Toxicity to microorganisms:

EC50: > 937 mg/l
Exposure time: 30 min
Method: ISO 8192
Remarks: Based on data from similar materials

Toxicity to fish (Chronic toxicity):

NOEC: > 100 mg/l
Exposure time: 28 dSpecies: Oncorhynchus mykiss (rainbow trout)
Remarks: Based on data from similar materials

13 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

Persistence and degradability
Components:
Tocopherol:
Biodegradability:

Result: Not readily biodegradable.
Biodegradation: 20 %Exposure time: 28 d
Method: OECD Test Guideline 301F

Bioaccumulative potential
No data available
Mobility in soil
No data available
Other adverse effects
No data available
13. DISPOSAL CONSIDERATIONS
Disposal methods
Waste from residues:

Contaminated packaging:

Do not dispose of waste into sewer.
Dispose of in accordance with local regulations.
Empty containers should be taken to an approved waste handling site for recycling or disposal.
If not otherwise specified: Dispose of as unused product.

14. TRANSPORT INFORMATIONInternational Regulations
UNRTDG
Not regulated as a dangerous good
IATA-DGR
Not regulated as a dangerous good
IMDG-CodeNot regulated as a dangerous goodTransport in bulk according to IMO instruments
Not applicable for product as supplied.
Special precautions for user
Not applicable
15. REGULATORY INFORMATION
Safety, health and environmental regulations/legislation specific for the substance or mixture
The components of this product are reported in the following inventories:
AICS: not determined
14 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

DSL:

not determined

IECSC

:

not determined

Revision Date:

06.04.2024

Further information
Sources of key data used tocompile the Safety Data
Sheet

:

Internal technical data, data from raw material SDSs, OECD
eChem Portal search results and European Chemicals Agency, http://echa.europa.eu/

Date format:

dd.mm.yyyy

16. OTHER INFORMATION

Full text of other abbreviations
ACGIH: USA. ACGIH Threshold Limit Values (TLV)
IN OEL: India. Permissible levels of certain chemical substances inwork environment.
ACGIH / TWAIN OEL / TWA::

8-hour, time-weighted averageTime-Weighted Average Concentration (TWA) (8 hrs.)

AIIC - Australian Inventory of Industrial Chemicals; ANTT - National Agency for Transport byLand of Brazil; ASTM - American Society for the Testing of Materials; bw - Body weight; CMR Carcinogen, Mutagen or Reproductive Toxicant; DIN - Standard of the German Institute forStandardisation; DSL - Domestic Substances List (Canada); ECx - Concentration associated with
x% response; ELx - Loading rate associated with x% response; EmS - Emergency Schedule;
ENCS - Existing and New Chemical Substances (Japan); ErCx - Concentration associated with
x% growth rate response; ERG - Emergency Response Guide; GHS - Globally Harmonized System; GLP - Good Laboratory Practice; IARC - International Agency for Research on Cancer; IATA
- International Air Transport Association; IBC - International Code for the Construction andEquipment of Ships carrying Dangerous Chemicals in Bulk; IC50 - Half maximal inhibitory concentration; ICAO - International Civil Aviation Organization; IECSC - Inventory of Existing Chemical Substances in China; IMDG - International Maritime Dangerous Goods; IMO - International
Maritime Organization; ISHL - Industrial Safety and Health Law (Japan); ISO - International Organisation for Standardization; KECI - Korea Existing Chemicals Inventory; LC50 - Lethal Concentration to 50 % of a test population; LD50 - Lethal Dose to 50% of a test population (Median
Lethal Dose); MARPOL - International Convention for the Prevention of Pollution from Ships;
n.o.s. - Not Otherwise Specified; Nch - Chilean Norm; NO(A)EC - No Observed (Adverse) EffectConcentration; NO(A)EL - No Observed (Adverse) Effect Level; NOELR - No Observable EffectLoading Rate; NOM - Official Mexican Norm; NTP - National Toxicology Program; NZIoC - New
Zealand Inventory of Chemicals; OECD - Organization for Economic Co-operation and Development; OPPTS - Office of Chemical Safety and Pollution Prevention; PBT - Persistent, Bioaccumulative and Toxic substance; PICCS - Philippines Inventory of Chemicals and Chemical Substances; (Q)SAR - (Quantitative) Structure Activity Relationship; REACH - Regulation (EC) No
1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals; SADT - Self-Accelerating Decomposition Temperature; SDS - Safety Data Sheet; TCSI - Taiwan Chemical Substance Inventory; TDG - Transportation of Dangerous Goods; TECI - Thailand Existing Chemicals Inventory; TSCA - Toxic Substances Control Act (United States); UN - United Nations; UNRTDG - United Nations Recommendations on the Transport of Dangerous Goods; vPvB - Very Persistent and Very Bioaccumulative; WHMIS - Workplace Hazardous Materials Information System
15 / 16

SAFETY DATA SHEET
according to the Globally Harmonized System

Lynestrenol Formulation
Version
4.2

Revision Date:
06.04.2024

SDS Number:
462438-00017

Date of last issue: 30.09.2023
Date of first issue: 15.01.2016

The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its publication. The information is designed only as a guidance forsafe handling, use, processing, storage, transportation, disposal and release and shall not be
considered a warranty or quality specification of any type. The information provided relates only
to the specific material identified at the top of this SDS and may not be valid when the SDS material is used in combination with any other materials or in any process, unless specified in the text.
Material users should review the information and recommendations in the specific context of theirintended manner of handling, use, processing and storage, including an assessment of the appropriateness of the SDS material in the user’s end product, if applicable.
IN / EN

16 / 16